Status:
COMPLETED
Insulin for Hyperglycemia in Stroke Trial
Lead Sponsor:
National Institute of Neurosciences and Hospital, Dhaka
Conditions:
Hyperglycemia
Stroke, Acute
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Introduction: Glycemic control in acutely ill stroke patients with hyperglycemia is vital. Although insulin is the choice of anti-diabetic agent during acute stage, it is not clear which insulin regim...
Detailed Description
METHODOLOGY: Type of study: Single-center, open-label, randomized trial Place of Study: Department of Neurology, National Institute of Neurosciences \& Hospital, Dhaka. Study Period: February to Jun...
Eligibility Criteria
Inclusion
- • Patients admitted to adult neurology ward with acute stroke with
- Patients having hyperglycemia (capillary blood glucose ≥10 mmol/L in 2 or more occasions or having history of treatment for DM)
- Patients with age of 18-80 years of both sexes
- Patients or their attendants giving consent to take part in the study
Exclusion
- Patients with hyperglycemic emergencies (hyperglycemic hyperosmolar state or diabetic ketoacidosis)
- Pregnant patients
- Those not giving consent to participate in the study
Key Trial Info
Start Date :
April 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2021
Estimated Enrollment :
452 Patients enrolled
Trial Details
Trial ID
NCT04834362
Start Date
April 5 2021
End Date
June 25 2021
Last Update
December 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Neurosciences and Hospital
Dhaka, Bangladesh, 1207